2 Jul 2009 16:44
TR1: NOTIFICATION OF MAJOR INTEREST IN SHARES | ||||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii | Provexis plc | |||
2 Reason for the notification (please tick the appropriate box or boxes): | ||||
An acquisition or disposal of voting rights | X | |||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | ||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | ||||
An event changing the breakdown of voting rights | ||||
Other (please specify): | ||||
3. Full name of person(s) subject to the notification obligation: iii | ANGLE plc | |||
4. Full name of shareholder(s) (if different from 3.):iv | ANGLE Technology Limited Progeny bioVentures Limited | |||
5. Date of the transaction and date on which the threshold is crossed or reached: v | 30 June 2009 and 1 July 2009 | |||
6. Date on which issuer notified: | 1 July 2009 | |||
7. Threshold(s) that is/are crossed or reached: vi, vii | Falls below 6% |
8. Notified details: | ||||||||||||||||
A: Voting rights attached to shares viii, ix | ||||||||||||||||
Class/type of shares
| Situation previous to the triggering transaction | Resulting situation after the triggering transaction | ||||||||||||||
Number of Shares | Number of Voting Rights | Number of shares | Number of voting rights | % of voting rights x | ||||||||||||
Direct | Direct xi | Indirect xii | Direct | Indirect | ||||||||||||
Ordinary shares ISIN code GB00B0923P27 | 65,145,643 | 65,145,643 | 42,395,643 | 42,395,643 | 5.2% | |||||||||||
B: Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financial instrument | Expiration date xiii | Exercise/ Conversion Period xiv | Number of voting rights that may be acquired if the instrument is exercised/ converted. | % of voting rights | ||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financial instrument | Exercise price | Expiration date xvii | Exercise/ Conversion period xviii | Number of voting rights instrument refers to | % of voting rights xix, xx | |||||||||||
Nominal | Delta | |||||||||||||||
Total (A+B+C) | ||||||||||||||||
Number of voting rights | Percentage of voting rights | |||||||||||||||
42,395,643 | 5.2% |
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi | ||
The ordinary shares in Provexis plc are owned by: ANGLE Technology Limited - in respect of 20,426,464 shares Progeny bioVentures Limited - in respect of 21,969,179 shares ANGLE plc owns: 100% of ANGLE Technology Limited; and 96.5% of Progeny bioVentures Limited | ||
Proxy Voting: | ||
10. Name of the proxy holder: | ||
11. Number of voting rights proxy holder will cease to hold: | ||
12. Date on which proxy holder will cease to hold voting rights: | ||
13. Additional information: | ||
14. Contact name: | Ian Griffiths | |
15. Contact telephone number: | 01483 685830 |